DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01276 HENGRUI PHARMA

Closed Add to Porfolio
Key Financial Ratio (Fiscal Year: 12/2025)
Current 8.08X Oper Margin 27.9%
LT Debt/Equity 0.1% Net Margin 24.4%
Total Debt/Equity 0.1% Return on Equity 12.6%
Price/Book 6.15X Return on Assets 11.0%
(HKD 63.200) 2025-122024-122023-122022-12
Net Profit (MHKD) 8,576.116,733.504,738.384,377.87
Net Profit Growth (%) +27.4+42.1+8.2N/A
Earnings Per Share (HKD) 1.3191.060.7450.689
Earnings Per Share Growth (%) +24.4+42.3+8.1N/A
Dividend Per Share (HKD) 0.228No dividendNo dividendNo dividend
P/E* (X) 47.9059.6084.8091.67
Yield (%) 0.36N/AN/AN/A
Dividend Share (%) 17.30N/AN/AN/A
Book NAV (HKD) 10.282N/AN/AN/A
Auditors' Opinion UnqualifiedN/AN/AN/A
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-05-18 21:40:21

Latest Result

(RMBMn) 2026-03 Chg* (%)
Cover Period (mths) 3 NA
Turnover 0 N/A
Operating Result 0 N/A
Associates 0 N/A
Profit Before Taxation 0 N/A
Taxation 0 N/A
Profit /( Loss) After Taxation 0 N/A
Minority Interests 0 N/A
Net Profit 0 N/A
Earnings Per Share () N/A N/A
Dividend Per Share () 0.0000 N/A
Announcement Date 2026-04-22 NA
* Annualised
Last Update Time: 2026-05-18 21:40:26
Back to Top